AzTrials
AzTrials

Dental MalpositionORTHO-IOPNCT05851963

Toothbrushes in Daily Practice in Patients With Fixed Orthodontic Appliances

A study testing Sonicare Diamond Clean 9000, HydroSonic Pro and Oral-B 123 in people with Dental Malposition, run by Claude Bernard University at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Because of the difficulties of disorganizing the dental biofilm in these adolescents with fixed orthodontic treatment, electric toothbrushes have been proposed as an alternative to manual toothbrushes. Read more about this study

Who is it for?
Ages 11 to 15 yearsHealthy volunteers can take part
Conditions the study is for
Dental Malposition
What is being tested?
Sonicare Diamond Clean 9000, HydroSonic Pro and Oral-B 123
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
120 participants
Where
1 siteFrance
Study dates
1 Apr 2025to 20 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 15 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Children to be treated with fixed upper and lower braces
  • 11 to 15 years of age at the start of treatment
  • One parent/legal guardian agrees to the terms and conditions of the study and signs the informed consent form
  • The adolescent agrees to the terms and conditions of the study and signs the informed consent form

Who cannot join

  • Less than 20 permanent teeth with braces or brackets
  • Presence of untreated cavities
  • Bleeding greater than 10% on probing
  • Presence of a gingival pocket larger than 5 mm
  • Presence of fixed prosthetic restorations
  • Presence of any enamel development defect
Show all 14Show fewer
  • Presence of dental anomalies or direct/indirect labial restorations on teeth
  • Patients requiring orthognathic surgeries
  • Presence of systemic diseases (diabetes, hepatic, renal, hematologic, cardiovascular)
  • Use of medications that may affect gingival health (such as calcium channel blockers, ciclosporin and anticoagulants)
  • Use of antibiotics and anti-inflammatory drugs for any purpose over a long period of time.
  • Having a smoking habit
  • Having a physical or mental problem that affects manual dexterity
  • Being unable to answer questions or being uncooperative

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • Centre de soin dentaire

    Nancy

    Céline Clément

    Recruiting

Other trials in France

About this study

Official title: Comparison of the Effectiveness of Manual and Electric Toothbrushes in Daily Practice in Patients With Fixed Orthodontic Appliances

Because of the difficulties of disorganizing the dental biofilm in these adolescents with fixed orthodontic treatment, electric toothbrushes have been proposed as an alternative to manual toothbrushes. Electric toothbrushes, available in a wide range of price points, have been developed with the goal of replicating the complex motions required by the manual toothbrush and making plaque removal more efficient. However, the overall effect size is limited, and the clinical relevance is not yet clear. Applied to orthodontics, specialized manual toothbrushes have also recently been developed. Few recent clinical trials have been conducted in patients with orthodontic appliances.

Thus, the question of whether and which type of manual or electric toothbrushes may be beneficial for patients with orthodontic appliances is still unresolved. Given the variety of toothbrushes available on the market, there is a need for sound clinical research to evaluate their effectiveness to guide professional recommendations. This work will provide a significant advance in the knowledge of the potential of the latest generation of electric toothbrushes on gingival inflammation, potentially reducing the risk of caries and gingival lesions.

Being tested
Sonicare Diamond Clean 9000, HydroSonic Pro, Oral-B 123, Curaprox CS 5460
Keywords
toothbrush, oral prophylaxis, adolescents, orthodontic appliances

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sonicare Diamond Clean 9000Device

    Brush teeth with the electric toothbrush 1 daily during the orthodontic treatment

  • HydroSonic ProDevice

    Brush teeth with the electric toothbrush 2 daily during the orthodontic treatment

  • Oral-B 123Device

    Brush teeth with the electric toothbrush 2 daily during the orthodontic treatment

  • Curaprox CS 5460Device

    Brush teeth with the electric toothbrush 2 daily during the orthodontic treatment

Study groups in NCT05851963
Study groupRoleWhat they receive
Group using sonic toothbrushExperimentalPatients will be asked to use a sonic toothbrush for 24 months
Receives: Device: Sonicare Diamond Clean 9000
Group using hydrosonic toothbrushExperimentalPatients will be asked to use a hydrosonic toothbrush for 24 months
Receives: Device: HydroSonic Pro
Group using manual toothbrushPlacebo comparatorPatients will be asked to use a manual toothbrush for 24 months
Receives: Device: Oral-B 123
Group using manual toothbrush with 5460 strandsExperimentalPatients will be asked to use a manual toothbrush with 5460 strands for 24 months
Receives: Device: Curaprox CS 5460

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of gingival bleeding from baseline during orthodontic treatment

    Change of gingival inflammation in patients with fixed orthodontic appliances using manual or electric toothbrushes in daily practice

    Measured: T1 (1 month), T2 (+ 3 months) and T3 (+ 6 months), T4 (+ 12 months), T5 (+ 15 months) T6 (+ 18 months) and T7 (+ 24 months)

Secondary outcomes (9)
  1. Acceptability

    Questionnaire to assess the acceptability of oral hygiene products by patients

    Measured: T1 (1 month), T2 (+ 3 months) and T3 (+ 6 months), T4 (+ 12 months), T5 (+ 15 months) T6 (+ 18 months) and T7 (+ 24 months)

  2. Effect on gingival inflammation

    gingival index

    Measured: T1 (1 month), T2 (+ 3 months) and T3 (+ 6 months), T4 (+ 12 months), T5 (+ 15 months) T6 (+ 18 months) and T7 (+ 24 months)

  3. Effect on gingival bleeding

    Bleeding on Probing

    Measured: T1 (1 month), T2 (+ 3 months) and T3 (+ 6 months), T4 (+ 12 months), T5 (+ 15 months) T6 (+ 18 months) and T7 (+ 24 months)

  4. Effect on dental plaque

    plaque index

    Measured: T1 (1 month), T2 (+ 3 months) and T3 (+ 6 months), T4 (+ 12 months), T5 (+ 15 months) T6 (+ 18 months) and T7 (+ 24 months)

  5. Effect on gingival tissue

    micro-osteoperforation

    Measured: T1 (1 month), T2 (+ 3 months) and T3 (+ 6 months), T4 (+ 12 months), T5 (+ 15 months) T6 (+ 18 months) and T7 (+ 24 months)

  6. Effect on gingival attachment

    clinical attachment loss

    Measured: T1 (1 month), T2 (+ 3 months) and T3 (+ 6 months), T4 (+ 12 months), T5 (+ 15 months) T6 (+ 18 months) and T7 (+ 24 months)

  7. Enamel lesions

    Assess the incidence of initial enamel lesions

    Measured: T1 (1 month), T2 (+ 3 months) and T3 (+ 6 months), T4 (+ 12 months), T5 (+ 15 months) T6 (+ 18 months) and T7 (+ 24 months)

  8. Dentinal hypersensitivity

    Assess the incidence of dentinal hypersensitivity

    Measured: T1 (1 month), T2 (+ 3 months) and T3 (+ 6 months), T4 (+ 12 months), T5 (+ 15 months) T6 (+ 18 months) and T7 (+ 24 months)

  9. Salivary acidity

    Measure of pH

    Measured: T1 (1 month), T2 (+ 3 months) and T3 (+ 6 months), T4 (+ 12 months), T5 (+ 15 months) T6 (+ 18 months) and T7 (+ 24 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 May 2023
  2. Study start1 Apr 2025
  3. Primary completion26 Dec 2026 (estimated)
  4. Study completion20 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Parallel Assignment This trial is designed as an four-arm parallel cluster randomized controlled trial and an allocation ratio of 1:1:1:1
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05851963
Sponsor's protocol ID
ORTHO-IOP
Acronym
ORTHO-IOP
Status last verified
Mar 2026
First submitted
30 Mar 2023
Last updated
18 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Sonicare Diamond Clean 9000, HydroSonic Pro and Oral-B 123 in people with Dental Malposition, run by Claude Bernard University at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 18 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Florence Carrouel, PhD (0478785745 ext. +33, florence.carrouel@univ-lyon1.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of gingival bleeding from baseline during orthodontic treatment (time frame: T1 (1 month), T2 (+ 3 months) and T3 (+ 6 months), T4 (+ 12 months), T5 (+ 15 months) T6 (+ 18 months) and T7 (+ 24 months)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in